CDC: Updated booster reduces risk of COVID-19 hospital visit
A COVID-19 bivalent vaccine booster provides additional protection against COVID-19–associated emergency department/urgent care encounters and hospitalizations compared with previous vaccination with two or more monovalent vaccine doses, according to studies in adults and older adults released today by the Centers for Disease Control and Prevention.
“To maximize protection against severe COVID-19 this winter season, all eligible persons, especially adults aged ≥65 years, should receive a bivalent booster dose and consider additional prevention strategies, including masking in indoor public spaces,” the study in older adults concludes.
Related News Articles
Headline
Just in time for March Madness, AHA is offering for hospitals and health systems a social media toolkit that uses the wildly popular NCAA basketball tournament…
Headline
The Food and Drug Administration yesterday amended its emergency use authorization for Pfizer’s updated COVID-19 vaccine to allow children aged 6 months…
Headline
Completing the Moderna or Pfizer COVID-19 monovalent vaccine primary series protects children aged 3-5 and 3-4, respectively, against symptomatic SARS-CoV-2…
Headline
AHA is offering for hospitals and health systems a second social media toolkit for February with messages for promoting COVID-19 vaccination and boosters. The…
Headline
A new video from AHA and the Children’s Hospital Association is reminding the public how vaccines and boosters are safe, effective means for preventing…
Headline
In a new public service announcement, leaders of the AHA, American Medical Association and American Nurses Association encourage the public to get vaccinated…